A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321
about
Combination therapeutics in complex diseasesOvercoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.Effects of carbon ion irradiation and X-ray irradiation on the ubiquitylated protein accumulation.Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack.Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma.Proteasome-associated deubiquitinases and cancer.Positioning of proteasome inhibitors in therapy of solid malignancies.Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity.
P2860
Q28076891-DE4EF6DA-40FE-4BCD-95AC-A9E95DBF056EQ33841579-6064B4EC-8956-40EC-B05C-684C2A95D196Q36368864-A6148D22-B7BD-47CB-9110-56009D609CF9Q36992155-2A8F292F-6500-4245-ADF9-6D37B9822ECFQ38809124-0F90BA1F-B4A9-4C8D-9500-991828841F86Q41291592-FE73365B-8D73-476A-9D01-B73280D1D4D8Q47161331-678619D0-E283-4A45-8BFB-FDC33B53A2B2Q47353792-0F4CE971-B3A2-495E-9C4F-9BABBCCC8713Q52538370-3363722B-171B-4FB4-AD46-F20C8297497C
P2860
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A phase I/II study of bortezom ...... Treatment Group (NCCTG)-N0321
@ast
A phase I/II study of bortezom ...... Treatment Group (NCCTG)-N0321
@en
type
label
A phase I/II study of bortezom ...... Treatment Group (NCCTG)-N0321
@ast
A phase I/II study of bortezom ...... Treatment Group (NCCTG)-N0321
@en
prefLabel
A phase I/II study of bortezom ...... Treatment Group (NCCTG)-N0321
@ast
A phase I/II study of bortezom ...... Treatment Group (NCCTG)-N0321
@en
P2093
P2860
P1476
A phase I/II study of bortezom ...... Treatment Group (NCCTG)-N0321
@en
P2093
Alex A Adjei
Bassam I Mattar
David B Johnson
Donald W Northfelt
James D Bearden
Jeffrey P Meyers
Julian R Molina
Kendrith M Rowland
Marie-Christine Aubry
Nathan R Foster
P2860
P304
P356
10.1097/JTO.0000000000000383
P577
2015-01-01T00:00:00Z